Real-world evidence on the use of daratumumab, bortezomib and dexamethasone (DVd) in lenalidomide-refractory myeloma patients: subgroup analysis of the multicenter retrospective experience by "rete ematologica pugliese".
Giuseppe MeleNicola Di RenzoNicola CascavillaAngelo Michele CarellaAttilio GuariniPatrizio MazzaLorella MelilloVincenzo PavoneGiuseppe TarantiniPaola CurciAnna P FalconeCandida GermanoAnna MeleFrancesca MerchionneGiulia PalazzoGaetano PalumboAngela Maria QuintoGiovanni ReddicontoBernardo RossiniAlessandro SpinaNicola SgherzaGiorgina SpecchiaPellegrino MustoDomenico PastorePublished in: Leukemia & lymphoma (2023)